Giuseppe Trojano

Giuseppe Trojano

Auto-generated profile, based on publicly available information

Giuseppe Trojano

2nd Unit of Obstetrics and Gynecology, Department of Biomedical and Human Oncological Science (DIMO), University of Bari, Bari, Italy

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2017 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
ECEttore Cicinelli
Ettore Cicinelli
MMMaria Matteo
Maria Matteo
GTGiueseppe Trojano
Giueseppe Trojano
PMPaola C. Mitola
Paola C. Mitola
RTRaffaele Tinelli
Raffaele Tinelli
LRLeonardo Resta
Leonardo Resta

1 August 2017 in Fertility and Sterility
Verified
Journal Article
Closed access
ECEttore Cicinelli
Ettore Cicinelli
GTGiuseppe Trojano
Giuseppe Trojano
MMMarcella Mastromauro
Marcella Mastromauro
AVAntonella Vimercati
Antonella Vimercati
MMMarco Marinaccio
Marco Marinaccio
DZDominique de Ziegler
Dominique de Ziegler

2 January 2017 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
MNMariateresa Natrella
Mariateresa Natrella
ENEdoardo Di Naro
Edoardo Di Naro
MLMatteo Loverro
Matteo Loverro
NBNeta Benshalom-Tirosh
Neta Benshalom-Tirosh
GTGiuseppe Trojano
Giuseppe Trojano
SMSalvatore Andrea Mastrolia
Salvatore Andrea Mastrolia
Midwives and nurses have a key role in monitoring postpartum period. They represent the first line professional figure in quantifying blood loss, initiating early diagnosis of obstetric hemorrhage, and mobilizing a team response, if needed. These actions are crucial in determining maternal outcome in postpartum hemorrhage (PPH). In our review we aimed to: (1) Provide a picture of PPH including its pathophysiology, epidemiology, and associated complications; (2) Discuss diagnosis of this dangerous postpartum event; and, (3) Especially evaluate the efficiency of the employment of visual blood loss estimation as a rapid way to suspect PPH and activate the patient assessment.

11 February 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Daniele VergaraDaniele Vergara
Daniele Vergara
WCWilliam H. Catherino
William H. Catherino
GTGiuseppe Trojano
Giuseppe Trojano
ANDREA TINELLIANDREA TINELLI
ANDREA TINELLI
Uterine fibroids (UFs) are the most common benign gynecological tumors. It was estimated that fifty percent of women presenting with UFs has symptomatology that negatively influences their quality of life. Pharmacological and/or surgical treatments are frequently required, depending on the woman’s desire to preserve fertility, with a high impact on healthcare costs. Generally, the use of currently available pharmacological treatments may lead to side effects. Therefore, there is a growing interest in a natural and safe approach for UFs. In recent years, epidemiological studies reported a vitamin D deficiency in patients with UFs raised interest in the potential biological effects of vitamin D supplementation. In vitro studies proved vitamin D efficacy in inhibiting UFs growth by targeting pathways involved in the regulation of various biological processes, including proliferation, extracellular matrix (ECM) remodeling, DNA repair, signaling and apoptosis. However, clinical studies supported only in part the beneficial effects of vitamin D supplementation in reducing UFs growth and tumor volume. Randomized controlled trials and large population studies are mandatory as the potential clinical benefits are likely to be substantial.

8 March 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
ECEttore Cicinelli
Ettore Cicinelli
Amerigo VitaglianoAmerigo Vitagliano
Amerigo Vitagliano
VLVera Loizzi
Vera Loizzi
Dominique de ZieglerDominique de Ziegler
Dominique de Ziegler
Margherita FanelliMargherita Fanelli
Margherita Fanelli
LVLuigi Viggiano
Luigi Viggiano
To evaluate the expression of genes encoding cytokines, grow factors and cell cycle regulators in the proliferative endometrium of women with chronic endometritis (CE) compared to controls. We performed a case-control study on seven women with CE as diagnosed by hysteroscopy and histology (Cases) compared to six women without CE (Controls). All women underwent diagnostic hysteroscopy plus endometrial biopsy during the mid-proliferative phase of the menstrual cycle. Endometrial samples were divided into two different aliquots for histological and molecular analyses. The endometrial expression profile of 16 genes encoding proteins involved in the inflammatory process, proliferation and cell cycle regulation/apoptosis was assessed by using high-throughput qPCR. Study endpoints were between-group differences in the expression of VEGF A, VEGF B, VEGF C, EGF, TNF, TGF B1, IFNG, TP73, TP73L, BAXva, CDC2, CDC2va, CCND3, CCNB1, BAX and IL12. RESULTS: VEGF A, VEGF B, VEGF C, EGF, TNF, TGF B1, IFNG, TP73, TP73L, BAXva, CDC2, CDC2va, CCND3, CCNB1 were significantly overexpressed in women with CE compared to controls, while BAX and IL12 had similar expression between groups. In women with CE, we found an altered endometrial expression of genes involved in inflammatory, cell proliferation, and apoptosis processes. The dominance of proliferative and anti-apoptotic activity in CE may potentially promote the development of polyps and hyperplastic lesions.

1 January 2018 in Gynecology and Minimally Invasive Therapy
Verified
Journal Article
Open access
PDF file
Gianluca Raffaello DamianiGianluca Raffaello Damiani
Gianluca Raffaello Damiani
GTGiuseppe Trojano
Giuseppe Trojano
VCVita Caroli Casavola
Vita Caroli Casavola
RLRossella Loiacono
Rossella Loiacono
AMAntonio Malvasi
Antonio Malvasi
LBLorella Battini
Lorella Battini
Backgrounds and Aims: This study aims to compare hysteroscopic and histological findings in asymptomatic postmenopausal patients with thickened endometrium. Materials and Methods: A retrospective study involving case records of 295 asymptomatic postmenopausal women with a thickened endometrium >5 mm diagnosed at transvaginal ultrasound (TVS). Patients (women) underwent hysteroscopy with biopsy between 2009 and 2015, and they were followed up at National Cancer Institute of Bari and at University Hospital of Pisa. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of hysteroscopy were evaluated. Results: Inclusion criteria were TVS, hysteroscopy, and endometrial biopsy. When the hysteroscopic findings were normal, a sensitivity of 100%, specificity of 98.6%, PPV of 95.2%, and NPV of 100% were achieved. For polyps and myomas, we found 100%, 98.7%, 99.5%, and 100%, respectively. In case of endometrial hyperplasia, a sensitivity of 66.7%, a specificity of 100%, a PPV of 100%, and a NPV of 98.1% were achieved. For endometrial cancer hysteroscopy, sensitivity, specificity, PPV, and NPV were 100%, 99.6%, 75%, and 100%, respectively. Conclusions: Hysteroscopy allows an accurate diagnosis in benign endometrial pathology and suspect of malignant endometrial pathology in postmenopausal women with thickened endometrium.